This is the limited version of the Conforma Therapeutics company profile: Join LinkedIn or Sign In to see more information.
As per the transaction announced on May 2, 2006, Conforma Therapeutics Corporation was acquired by Biogen Idec, Inc. Conforma Therapeutics Corporation, a biopharmaceutical company, focuses on the design and development of drugs for the treatment of cancer. It develops drugs that induce tumor cells to degrade the proteins that promote cancer growth. The company offers the HSP90 product, CNF1010, which is used for the treatment of cancer. Conforma Therapeutics was founded in 1999 and is based in San Diego, California.
In partnership with 
Send feedback on BusinessWeek/CapIQ content to linkedinissues@capitaliq.com. Copyright © 2009 Capital IQ.
This LinkedIn Company Profile was created by LinkedIn and is about Conforma Therapeutics. This page is not endorsed by or affiliated with Conforma Therapeutics. For questions regarding LinkedIn Company Profiles, contact us.
Conforma Therapeutics full company profile, top executives, board of directors & more.
| 